In vitro, CsA significantly inhibited the production of IL-17 and IFN-γ by PBMCs activated with anti-CD3 and anti-CD28 antibodies or phorbol 12-myristate,13-acetate and ionomycin in BD patients with active uveitis. Here, IL17A is linked to uveitis.